Tag:
Smith & Nephew
Latest Headlines
Latest Headlines
Smith & Nephew CEO: Lack of innovation begats plunging industry margins
The medical device industry is boring. It doesn't innovate. And that, rather than government austerity, is why companies continue to face falling margins. Before you write that off as a conclusion coming from an outside consultant, consider that it comes from one of the industry's major figures: Smith & Nephew ($SNN) CEO Olivier Bohuon.
Smith & Nephew sees good quarter with knees, AWM
Knees, sports medicine joint repair, and advanced wound management (AWM) helped boost Smith & Nephew ($SNN) to a good first quarter, as revenues rose 3% to $1.08 billion.
Smith & Nephew eliminating 800 jobs, restructuring already felt in Memphis
It has been a tough few days for medical device manufacturer Smith & Nephew ($SNN) and particularly for its Memphis, TN-based division. The company announced Monday that it would pay the U.S.
UPDATED: Smith & Nephew settles with gov't over bribery allegations, impresses with earnings announcement
Smith & Nephew ( $SNN ) will pay about $22 million after reaching a settlement with the Securities and Exchange Commission and Department of Justice over allegations its subsidiaries paid bribes to
S&N spins off drug unit into private-equity JV
Devicemaker Smith & Nephew ( $SNN ) is hiving off its biologic drugs division. The biologics business will become a joint venture majority-owned by the private equity firm Essex Woodlands; in
Smith & Nephew to spin off biologics unit into JV
Smith & Nephew ( $SNN ) has agreed to spin off its biologics and clinical therapies business into a joint venture--dubbed Bioventus--with venture capital firm Essex Woodlands. The resulting entity
Report: S&N to raise R&D budget
Smith & Nephew ( $SNN ) will up its R&D budget by $300 million over the next 5 years as it looks to pump up sales in the so-called BRIC countries. The company hopes to raise sales in these
S&N takeover rumors rekindled
Smith & Nephew is back in the news as a potential takeover target with Biomet and Stryker ( $SYK ) named as suitors. Warsaw, IN-based Biomet is rumored to be planning an £8 billion ($13
Knees help propel Smith & Nephew to a good Q2
Smith & Nephew discussed its second-quarter financial results last week, and the U.K. company had some good results. During the quarter, the company generated revenues of a bit under $1.08
Smith & Nephew buys TENET Medical Engineering
Smith & Nephew has acquired Calgary, Alberta-based TENET Medical Engineering on behalf of its endoscopy division. TENET markets technology in the area of patient positioning, including intuitive
